Literature DB >> 34609483

Alternative Causes of Infectious Diarrhea in Patients with Negative Tests for Clostridoides Difficile.

Jennie H Kwon1, Caroline A O'Neil1, Tiffany Hink1, Kimberly A Reske1, Rachel E Bosserman1, Erik R Dubberke1, Carey-Ann D Burnham2.   

Abstract

BACKGROUND: Hospitalized patients with diarrhea who have a negative Clostridoides difficile (C. difficile) test are not routinely evaluated for alternative causes of infectious diarrhea. This study assessed for potential infectious causes of diarrhea in hospitalized patients with an order for repeat C. difficile toxin enzyme immunoassay (tEIA) testing after an initial tEIA test was negative.
METHODS: For patients age ≥18 years who had a second C. difficile tEIA test ordered within 96 h after a negative tEIA test, remnant fecal specimens from the first (negative) tEIA test were evaluated using the BioFire FilmArray Gastrointestinal Panel PCR, C. difficile toxigenic culture, and culture on a blood agar plate (BAP) to identify other potential causes of infectious diarrhea. Growth of organisms on the BAP was also used to assess potential disruptions in the gastrointestinal microbiota.
RESULTS: Among 84 remnant specimens, toxigenic C. difficile was identified in 9 (11%) by culture or PCR, while potential alternative causes of infectious diarrhea, including norovirus, rotavirus, enteropathogenic Escherichia coli, and Salmonella, were identified in 11 specimens (13%) by PCR. For the majority of patients, no infectious cause of diarrhea was identified, but 84% exhibited disrupted gastrointestinal microbiota, which may contribute to diarrhea.
CONCLUSIONS: When a hospitalized patient has a negative C. difficile tEIA test but continues to have diarrhea, alternative infectious and noninfectious causes of diarrhea should be considered. If the patient has clinical signs and symptoms suggestive of infection or risk factors for gastrointestinal infection, laboratory testing for other etiologic agents may be appropriate. © American Association for Clinical Chemistry 2021. All rights reserved. For permissions, please email: journals.permissions@oup.com.

Entities:  

Keywords:  zzm321990 Clostridoides difficilezzm321990 ; diarrhea; infectious diarrhea

Mesh:

Year:  2022        PMID: 34609483      PMCID: PMC8889093          DOI: 10.1093/jalm/jfab110

Source DB:  PubMed          Journal:  J Appl Lab Med        ISSN: 2475-7241


  14 in total

1.  Practice guidelines for the management of infectious diarrhea.

Authors:  R L Guerrant; T Van Gilder; T S Steiner; N M Thielman; L Slutsker; R V Tauxe; T Hennessy; P M Griffin; H DuPont; R B Sack; P Tarr; M Neill; I Nachamkin; L B Reller; M T Osterholm; M L Bennish; L K Pickering
Journal:  Clin Infect Dis       Date:  2001-01-30       Impact factor: 9.079

2.  Comparative evaluation of two commercial multiplex panels for detection of gastrointestinal pathogens by use of clinical stool specimens.

Authors:  Reeti Khare; Mark J Espy; Elizabeth Cebelinski; David Boxrud; Lynne M Sloan; Scott A Cunningham; Bobbi S Pritt; Robin Patel; Matthew J Binnicker
Journal:  J Clin Microbiol       Date:  2014-08-06       Impact factor: 5.948

Review 3.  The role of multiplex molecular panels for the diagnosis of gastrointestinal infections in immunocompromised patients.

Authors:  Rachael M Liesman; Matthew J Binnicker
Journal:  Curr Opin Infect Dis       Date:  2016-08       Impact factor: 4.915

4.  Low Yield of FilmArray GI Panel in Hospitalized Patients with Diarrhea: an Opportunity for Diagnostic Stewardship Intervention.

Authors:  Matthew M Hitchcock; Carlos A Gomez; Niaz Banaei
Journal:  J Clin Microbiol       Date:  2018-02-22       Impact factor: 5.948

5.  Clinical Practice Guidelines for Clostridium difficile Infection in Adults and Children: 2017 Update by the Infectious Diseases Society of America (IDSA) and Society for Healthcare Epidemiology of America (SHEA).

Authors:  L Clifford McDonald; Dale N Gerding; Stuart Johnson; Johan S Bakken; Karen C Carroll; Susan E Coffin; Erik R Dubberke; Kevin W Garey; Carolyn V Gould; Ciaran Kelly; Vivian Loo; Julia Shaklee Sammons; Thomas J Sandora; Mark H Wilcox
Journal:  Clin Infect Dis       Date:  2018-03-19       Impact factor: 9.079

6.  A Gastrointestinal PCR Panel Improves Clinical Management and Lowers Health Care Costs.

Authors:  Stacy G Beal; Elizabeth E Tremblay; Steven Toffel; Lymaries Velez; Kenneth H Rand
Journal:  J Clin Microbiol       Date:  2017-12-26       Impact factor: 5.948

7.  Multiplex gastrointestinal pathogen panels: implications for infection control.

Authors:  Kenneth H Rand; Elizabeth E Tremblay; Mari Hoidal; Lori B Fisher; Katrina R Grau; Stephanie M Karst
Journal:  Diagn Microbiol Infect Dis       Date:  2015-01-22       Impact factor: 2.803

8.  New multiplex PCR method for the detection of Clostridium difficile toxin A (tcdA) and toxin B (tcdB) and the binary toxin (cdtA/cdtB) genes applied to a Danish strain collection.

Authors:  S Persson; M Torpdahl; K E P Olsen
Journal:  Clin Microbiol Infect       Date:  2008-11       Impact factor: 8.067

9.  2017 Infectious Diseases Society of America Clinical Practice Guidelines for the Diagnosis and Management of Infectious Diarrhea.

Authors:  Andi L Shane; Rajal K Mody; John A Crump; Phillip I Tarr; Theodore S Steiner; Karen Kotloff; Joanne M Langley; Christine Wanke; Cirle Alcantara Warren; Allen C Cheng; Joseph Cantey; Larry K Pickering
Journal:  Clin Infect Dis       Date:  2017-11-29       Impact factor: 9.079

10.  Clostridium difficile colonization among patients with clinically significant diarrhea and no identifiable cause of diarrhea.

Authors:  Erik R Dubberke; Kimberly A Reske; Tiffany Hink; Jennie H Kwon; Candice Cass; Jahnavi Bongu; Carey-Ann D Burnham; Jeffrey P Henderson
Journal:  Infect Control Hosp Epidemiol       Date:  2018-09-18       Impact factor: 3.254

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.